RAPT Therapeutics, Inc.

NASDAQ:RAPT

2.89 (USD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Operating Activities:
Net Income -27.663-30.521-30.876-31.371-25.28-29.271-22.951-21.235-19.184-20.468-17.929-18.651-16.11-16.514-12.735-14.631-12.387-13.139-13.216-9.967-10.626-9.188-9.43-10.282-8.204-8.231
Depreciation & Amortization 0.3050.3140.3230.3250.2690.2990.2520.260.2740.2610.2310.2290.2560.280.2650.2630.3960.1990.3190.3420.3380.3310.2940.3090.3220.312
Deferred Income Tax 00-5.146-1.564-2.16200000000012.72200000.02400-0.0330.0500
Stock Based Compensation 5.3845.3984.4294.3294.2394.0943.0252.8652.6722.7022.0862.2912.8882.6872.5582.0052.0352.0880.8960.4310.3470.3770.2960.2940.2860.294
Change In Working Capital -6.016-1.876-0.995.814-6.4587.133-2.910.315-0.0991.359-5.4763.029-1.232-0.619-5.4992.2633.6731.9076.35-2.9910.926-0.152-0.3320.7690.3360.011
Accounts Receivables 000000000000005.0105.01-5.0100000000
Change In Inventory 00000000000000-6.37600-0.56200000000
Change In Accounts Payables -6.427-0.728-0.0716.378-6.2497.277-0.2630.6731.4091.891-2.6183.080.1090.362-2.8173.396-0.612.421-1.451-0.9043.0420.049-0.0411.712-0.073-0.123
Other Working Capital 0.411-1.148-0.919-0.564-0.209-0.144-2.647-0.358-1.508-0.532-2.858-0.051-1.341-0.981-1.316-1.1334.2835.0587.801-2.087-2.116-0.201-0.291-0.9430.4090.134
Other Non Cash Items 12.2576.3554.5060.5830.584-0.857-0.2650.6461.1420.5680.4070.5830.2820.256-12.6770.147-0.1440.2-0.0370.0220.002-0.002-0.006-0.003-0.002-0.003
Operating Cash Flow -28.154-27.084-27.754-21.884-28.808-18.602-22.849-17.149-15.195-15.578-20.681-12.519-13.916-13.91-15.366-9.953-6.427-8.745-5.688-12.139-9.013-8.634-9.211-8.863-7.262-7.617
Investing Activities:
Investments In Property Plant And Equipment 0.001-0.105-0.067-0.066-0.233-0.759-0.049-0.081-0.566-0.149-0.394-0.07-0.064-0.227-0.174-0.1260-0.098-0.025-0.076-0.368-0.419-1.654-0.796-0.613-0.437
Acquisitions Net 00-20.706-25.815-32.67-26.06741.22117.5189.89200000800000000000
Purchases Of Investments -17.193-16.814-55.259-32.287-36.073-37.878-78.138-40.477-66.186-6.055-16.927-29.345-102.971-15.734-16.628-10.814-65.009-46.88300000000
Sales Maturities Of Investments 36.40532.80675.96558.10268.74363.94536.91722.95956.29430.0411.42915.24139.34328.37232.297128000000000
Other Investing Activites 19.21215.99220.70625.81532.6726.067-41.221-17.518-9.89223.986-15.498-14.104-63.62812.638-81.1868-46.8830.0450000000
Investing Cash Flow 19.21315.88720.63925.74932.43725.308-41.27-17.599-10.45823.837-15.892-14.174-63.69212.41115.4951.06-57.009-46.9810.02-0.076-0.368-0.419-1.654-0.796-0.613-0.437
Financing Activities:
Debt Repayment 00000000000000000000000000
Common Stock Issued 0.7019.0360.4580.1060.7670.11675.0254.97949.7840.1320.1880.472138.0921.184.0750.4110.45369.84234.7410.6820.0340.0660.0680.0620.0460.09
Common Stock Repurchased 000000000000000.896000.030.802000000-0.003
Dividends Paid 00000000000000000000000000
Other Financing Activities 0.7010.0670.4580.1060.7670.1160.3340.2720.6540.1320.4130.4721.0160.1214.560.1650.86469.87234.7410.6637.4857.01322.5540.06229.9170.087
Financing Cash Flow 0.7019.0360.4580.1060.7670.11675.3595.25150.4380.1320.6010.472139.1081.3014.560.1650.86469.87234.7410.6637.4857.01322.6220.06229.9630.087
Other Information:
Effect Of Forex Changes On Cash 00-0.2010.358-0.157000000000000000000000
Net Change In Cash -8.24-2.161-6.6573.9714.3966.82211.24-29.49724.7858.391-35.972-26.22161.5-0.1984.689-8.728-62.57214.14629.073-11.552-1.896-2.0411.757-9.59722.088-7.967
Cash At End Of Period 37.07745.31747.47854.13550.16445.76838.94627.70657.20332.41824.02759.99986.2224.7224.91820.22928.95791.52977.38348.3159.86261.75863.79852.04161.63839.55